PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Cash Flow from Financing Activities | ₹-422 Cr | ₹818 Cr | ₹794 Cr | ₹3,977 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-422 Cr |
Mar2023 | ₹818 Cr |
Mar2022 | ₹794 Cr |
Mar2021 | ₹3,977 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-422 Cr | Negative | |
Mar2023 | ₹818 Cr | 2.97 | |
Mar2022 | ₹794 Cr | -80.03 | |
Mar2021 | ₹3,977 Cr | - |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹25,680.1 Cr | -3.4% | -6.1% | 27.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | -1% | -0.5% | 13.2% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -3.4% |
-6.1% |
27.4% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses